Morgan Jess S & CO Inc Medicinova Inc Transaction History

Morgan Jess S & CO Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Nov 30, 2021	SELL	$3.76 - $5.14 $1.88 Million - $2.56 Million	-498,688 Closed	0 $0
Q1 2021 Nov 30, 2021	BUY	$4.81 - $8.74 $687,685 - $1.25 Million	142,970 Added 40.19%	498,688 $2.52 Million
Q4 2020 Nov 30, 2021	BUY	$5.03 - $6.31 $18,827 - $23,618	3,743 Added 1.06%	355,718 $1.87 Million
Q3 2020 Nov 29, 2021	BUY	$4.67 - $11.0 $1.64 Million - $3.87 Million	351,975 New	351,975 $1.84 Million

5.1M

28.5K

Ticker MNOV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 49,046,200
Market Cap $62.8M
Description
MediciNova, Inc., a biopharmaceutical company, focuses on developing novel and small molecule therapeutics for the treatment of serious diseases with unmet medical needs in the United States. The company is developing MN-166 (ibudilast), an oral anti-inflammatory and neuroprotective agent for treating neurological disorders, such as primary and ...

Get notified when there are updates to the investment portfolio of Morgan Jess S & CO Inc, based on Form 13F filings with the SEC.

Stay updated on Morgan Jess S & CO Inc with notifications on news.